Lost in translation: bridging the gap between cancer research and effective therapies

52^nd Annual Meeting of the Italian Cancer Society (SIC), Rome, 4–7 October 2010.

Successful translation of the exciting results achieved in the understanding of the tumor pathobiology at the patient's bedside is probably the biggest challenge ahead in cancer research. Therefore, one of the main goals of the SIC Meeting was to ‘bridge the gap between cancer research and effective therapies’. The entire program was ideally comprised between the opening lecture on p53 by Karen Vousden (Glasgow, Scotland, UK) and the closing lecture on Cancer stem cells by Pier Giuseppe Pelicci (Milan, Italy), going through the traditional Giorgio Prodi lecture given by Marco Pierotti (Milan, Italy), who presented an overview of the progresses achieved in cancer research in the past 35 years.

Log in or create a free account to read this content

Gain free access to this article, as well as selected content from this journal and more on nature.com

Access through your institution

or

Sign in or create an account

Continue with Google

Continue with ORCiD